Antiprotozoal [EPC]

Antiprotozoal [EPC] was reported 10636 times

Drugs of the Antiprotozoal [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 MYELODYSPLASTIC SYNDROME WITH MULTILINEAGE DYSPLASIA 13 0.2549
1 PARASITE BLOOD TEST POSITIVE 8 0.2353
2 MALARIA 126 0.1787
3 IVTH NERVE PARALYSIS 42 0.1772
4 PHALANGEAL HYPOPLASIA 12 0.1690
5 PLASMODIUM FALCIPARUM INFECTION 19 0.1532
6 CONGENITAL ABSENCE OF CRANIAL VAULT 8 0.1379
7 ENCEPHALITIS PROTOZOAL 7 0.1250
8 CUTANEOUS MUCORMYCOSIS 21 0.1141
9 TOTAL LUNG CAPACITY INCREASED 27 0.0993
10 ACANTHAMOEBA INFECTION 17 0.0904
11 MICROSPORIDIA INFECTION 31 0.0883
12 CAMPYLOBACTER TEST POSITIVE 6 0.0789
13 CUTANEOUS NOCARDIOSIS 9 0.0692
14 MALACOPLAKIA 28 0.0611
15 DISSEMINATED TOXOPLASMOSIS 7 0.0583
16 PARASITIC GASTROENTERITIS 11 0.0573
17 PULMONARY NOCARDIOSIS 47 0.0570
18 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 27 0.0516
19 SPONTANEOUS BACTERIAL PERITONITIS 12 0.0492
20 PNEUMOCYSTIS JIROVECII INFECTION 56 0.0469
21 SCROTAL ULCER 11 0.0421
22 SUSPECTED DRUG-INDUCED LIVER INJURY 8 0.0400
23 GASTROENTERITIS CRYPTOSPORIDIAL 8 0.0394
24 GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION 10 0.0368
25 NOCARDIOSIS 94 0.0367
26 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 8 0.0362
27 CEREBELLAR STROKE 14 0.0358
28 CHEST WALL ABSCESS 7 0.0354
29 CRYPTOSPORIDIOSIS INFECTION 18 0.0343
30 MORGANELLA INFECTION 10 0.0341
31 PENILE ULCERATION 11 0.0336
32 DEVICE RELATED BACTERAEMIA 10 0.0323
33 BURKHOLDERIA CEPACIA COMPLEX INFECTION 8 0.0280
34 IGA NEPHROPATHY 46 0.0277
35 LEISHMANIASIS 8 0.0276
36 CONGENITAL FOOT MALFORMATION 12 0.0264
37 CONGENITAL APLASIA 8 0.0257
38 ANAEMIA MEGALOBLASTIC 11 0.0247
39 JARISCH-HERXHEIMER REACTION 16 0.0225
40 XANTHOPSIA 8 0.0217
41 GIARDIASIS 7 0.0205
42 TOXOPLASMOSIS 22 0.0204
43 CEREBRAL TOXOPLASMOSIS 18 0.0193
44 ENTEROCOCCAL BACTERAEMIA 20 0.0189
45 PROTEUS INFECTION 13 0.0181
46 HUMAN HERPESVIRUS 8 INFECTION 11 0.0181
47 DISSEMINATED MUCORMYCOSIS 7 0.0178
48 ARTERIOVENOUS FISTULA THROMBOSIS 6 0.0173
49 FUSARIUM INFECTION 12 0.0171
50 WOUND INFECTION BACTERIAL 7 0.0169
51 CHYLOTHORAX 12 0.0166
52 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 6 0.0165
53 PNEUMOCYSTIS JIROVECII PNEUMONIA 156 0.0155
54 VASOGENIC CEREBRAL OEDEMA 11 0.0153
55 LUNG TRANSPLANT REJECTION 10 0.0152
56 ZYGOMYCOSIS 7 0.0150
57 GRAFT VERSUS HOST DISEASE IN LUNG 7 0.0146
58 VANISHING BILE DUCT SYNDROME 16 0.0143
59 EVANS SYNDROME 7 0.0142
60 SYPHILIS 10 0.0138
61 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 68 0.0136
62 VULVAL DISORDER 9 0.0136
63 MIXED LIVER INJURY 41 0.0136
64 GASTROENTERITIS NOROVIRUS 18 0.0135
65 DISSEMINATED CRYPTOCOCCOSIS 10 0.0132
66 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 12 0.0130
67 NEURAL TUBE DEFECT 9 0.0124
68 ANAL ULCER 10 0.0122
69 HYPOMANIA 44 0.0120
70 SYSTEMIC CANDIDA 30 0.0119
71 NOROVIRUS INFECTION 17 0.0118
72 MARROW HYPERPLASIA 8 0.0117
73 IMMUNE RECONSTITUTION SYNDROME 15 0.0116
74 MYCOBACTERIAL INFECTION 20 0.0116
75 ACQUIRED IMMUNODEFICIENCY SYNDROME 6 0.0116
76 MUCORMYCOSIS 30 0.0115
77 DELAYED GRAFT FUNCTION 8 0.0113
78 GRAFT VERSUS HOST DISEASE 80 0.0111
79 GENE MUTATION 22 0.0111
80 ENTEROCOCCAL INFECTION 53 0.0110
81 COMA SCALE ABNORMAL 31 0.0107
82 METHAEMOGLOBINAEMIA 24 0.0104
83 CYTOMEGALOVIRUS TEST POSITIVE 18 0.0101
84 ENTEROCOCCAL SEPSIS 8 0.0099
85 PNEUMONIA FUNGAL 37 0.0094
86 JAUNDICE CHOLESTATIC 33 0.0093
87 THROMBOTIC MICROANGIOPATHY 90 0.0092
88 CYTOMEGALOVIRUS CHORIORETINITIS 18 0.0092
89 INFECTIOUS PLEURAL EFFUSION 14 0.0092
90 LICHENOID KERATOSIS 21 0.0092
91 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 54 0.0091
92 STAPHYLOCOCCAL SKIN INFECTION 11 0.0089
93 ENTEROBACTER INFECTION 15 0.0089
94 HEPATIC CYTOLYSIS 111 0.0087
95 PARAINFLUENZAE VIRUS INFECTION 13 0.0085
96 KLEBSIELLA BACTERAEMIA 8 0.0084
97 VOCAL CORD PARALYSIS 15 0.0084
98 KLEBSIELLA INFECTION 42 0.0083
99 CYTOMEGALOVIRUS VIRAEMIA 35 0.0079
100 PNEUMOCYSTIS JIROVECI PNEUMONIA 17 0.0076
101 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 7 0.0076
102 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 56 0.0075
103 GASTROINTESTINAL INJURY 20 0.0074
104 STAPHYLOCOCCAL BACTERAEMIA 32 0.0074
105 HISTOPLASMOSIS 13 0.0073
106 GRAFT VERSUS HOST DISEASE IN SKIN 16 0.0073
107 LISTERIOSIS 8 0.0072
108 VIRAEMIA 10 0.0072
109 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 15 0.0070
110 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 23 0.0070
111 RHINITIS ALLERGIC 31 0.0070
112 APHTHOUS STOMATITIS 16 0.0069
113 ANTICHOLINERGIC SYNDROME 11 0.0069
114 BONE MARROW TRANSPLANT 13 0.0068
115 ASPERGILLUS INFECTION 44 0.0067
116 GRANULOMATOSIS WITH POLYANGIITIS 8 0.0066
117 BICYTOPENIA 13 0.0066
118 LYME DISEASE 22 0.0066
119 FEBRILE BONE MARROW APLASIA 28 0.0066
120 PNEUMONIA KLEBSIELLA 12 0.0065
121 OTOTOXICITY 12 0.0065
122 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 9 0.0064
123 MYCOBACTERIUM AVIUM COMPLEX INFECTION 17 0.0063
124 ABORTION MISSED 8 0.0063
125 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 7 0.0062
126 CYTOKINE RELEASE SYNDROME 125 0.0062
127 PNEUMONIA CYTOMEGALOVIRAL 12 0.0062
128 RASH MORBILLIFORM 17 0.0061
129 ANAEMIA MACROCYTIC 13 0.0061
130 BLOOD PRESSURE SYSTOLIC ABNORMAL 15 0.0061
131 ESCHERICHIA BACTERAEMIA 14 0.0059
132 BK VIRUS INFECTION 20 0.0059
133 SARCOIDOSIS 28 0.0059
134 BRONCHIECTASIS 39 0.0058
135 AGRANULOCYTOSIS 106 0.0057
136 ORAL MUCOSA EROSION 7 0.0057
137 NASAL POLYPS 28 0.0057
138 PERSECUTORY DELUSION 14 0.0056
139 PULMONARY SEPSIS 8 0.0055
140 CYTOMEGALOVIRUS INFECTION REACTIVATION 24 0.0054
141 CHOLESTATIC LIVER INJURY 12 0.0054
142 BRONCHOPULMONARY ASPERGILLOSIS 41 0.0053
143 LUNG ABSCESS 11 0.0052
144 PNEUMONIA PSEUDOMONAL 8 0.0052
145 VASCULAR PSEUDOANEURYSM 9 0.0052
146 BRAIN ABSCESS 13 0.0051
147 IMMUNE-MEDIATED HEPATIC DISORDER 10 0.0051
148 THROMBOCYTOPENIC PURPURA 7 0.0051
149 FUNGAEMIA 8 0.0051
150 HISTOPLASMOSIS DISSEMINATED 8 0.0050
151 VARICELLA 12 0.0050
152 PNEUMOMEDIASTINUM 9 0.0050
153 ATYPICAL MYCOBACTERIAL INFECTION 7 0.0049
154 LUNG OPACITY 13 0.0049
155 BACTERAEMIA 58 0.0049
156 ORGANISING PNEUMONIA 24 0.0048
157 ADENOVIRUS INFECTION 14 0.0048
158 CYTOPENIA 59 0.0048
159 APLASTIC ANAEMIA 25 0.0048
160 OESOPHAGEAL CANDIDIASIS 19 0.0048
161 LEUKAEMIA RECURRENT 8 0.0047
162 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 13 0.0047
163 SCHIZOPHRENIA 57 0.0047
164 BLOOD AMYLASE INCREASED 8 0.0047
165 STEROID DIABETES 7 0.0047
166 TONGUE COATED 8 0.0046
167 MYOPIA 11 0.0046
168 PYELONEPHRITIS ACUTE 9 0.0046
169 ENCEPHALOPATHY 112 0.0046
170 TOXIC EPIDERMAL NECROLYSIS 69 0.0045
171 ESCHERICHIA INFECTION 37 0.0045
172 CENTRAL NERVOUS SYSTEM LYMPHOMA 6 0.0044
173 CYTOMEGALOVIRUS INFECTION 71 0.0043
174 OPTIC NEUROPATHY 9 0.0042
175 ACUTE MYELOID LEUKAEMIA RECURRENT 9 0.0042
176 HYPERURICAEMIA 17 0.0041
177 SLEEP TALKING 7 0.0041
178 TRANSPLANT REJECTION 33 0.0041
179 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 32 0.0041
180 PNEUMONIA STAPHYLOCOCCAL 8 0.0041
181 HYPERBILIRUBINAEMIA 42 0.0041
182 PANCYTOPENIA 225 0.0040
183 DIFFUSE LARGE B-CELL LYMPHOMA 31 0.0040
184 SPLENIC INFARCTION 7 0.0040
185 MENINGITIS CRYPTOCOCCAL 7 0.0040
186 EPSTEIN-BARR VIRUS INFECTION 25 0.0040
187 VENOOCCLUSIVE DISEASE 10 0.0040
188 FANCONI SYNDROME ACQUIRED 7 0.0040
189 SERUM FERRITIN INCREASED 21 0.0040
190 LUNG TRANSPLANT 14 0.0040
191 BLOOD PRESSURE DIASTOLIC ABNORMAL 10 0.0039
192 IMMUNE-MEDIATED HEPATITIS 8 0.0039
193 RASH MACULO-PAPULAR 87 0.0039
194 CALCULUS URINARY 6 0.0039
195 B-CELL LYMPHOMA 13 0.0038
196 PNEUMONIA BACTERIAL 35 0.0038
197 CHOLESTASIS 73 0.0038
198 RESPIRATORY SYNCYTIAL VIRUS INFECTION 33 0.0038
199 EYE CONTUSION 8 0.0038
200 FEBRILE NEUTROPENIA 250 0.0038
201 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 10 0.0038
202 TOOTH DISCOLOURATION 11 0.0037
203 DRUG RESISTANCE 95 0.0037
204 CRYPTOCOCCOSIS 6 0.0037
205 MOUTH ULCERATION 77 0.0037
206 VENOOCCLUSIVE LIVER DISEASE 18 0.0036
207 RHINOVIRUS INFECTION 14 0.0036
208 PULMONARY ALVEOLAR HAEMORRHAGE 20 0.0036
209 BRAIN DEATH 11 0.0036
210 KIDNEY TRANSPLANT REJECTION 17 0.0035
211 LUNG NEOPLASM 15 0.0035
212 READING DISORDER 8 0.0035
213 COVID-19 PNEUMONIA 41 0.0035
214 CARDIAC MURMUR 30 0.0035
215 FAILURE TO THRIVE 18 0.0035
216 HAEMOLYTIC URAEMIC SYNDROME 8 0.0034
217 DERMATITIS EXFOLIATIVE GENERALISED 12 0.0034
218 PARTIAL SEIZURES 18 0.0034
219 BILIRUBIN CONJUGATED INCREASED 8 0.0034
220 ANGIONEUROTIC OEDEMA 9 0.0034
221 BLOOD HIV RNA INCREASED 6 0.0033
222 CUTANEOUS VASCULITIS 12 0.0033
223 ACUTE GRAFT VERSUS HOST DISEASE 15 0.0033
224 TRANSPLANT FAILURE 8 0.0033
225 STAPHYLOCOCCAL SEPSIS 16 0.0032
226 CYSTITIS HAEMORRHAGIC 13 0.0032
227 CLOSTRIDIUM DIFFICILE COLITIS 34 0.0032
228 CLOSTRIDIUM TEST POSITIVE 7 0.0032
229 PSEUDOMONAS INFECTION 27 0.0031
230 ACUTE MYELOID LEUKAEMIA 49 0.0031
231 HEPATOTOXICITY 70 0.0031
232 HAEMOLYTIC ANAEMIA 28 0.0031
233 DERMATITIS ACNEIFORM 19 0.0031
234 HAEMOLYSIS 24 0.0031
235 COMPLICATIONS OF TRANSPLANTED KIDNEY 7 0.0031
236 PATHOGEN RESISTANCE 28 0.0031
237 ABSCESS LIMB 13 0.0030
238 CHRONIC GRAFT VERSUS HOST DISEASE 11 0.0030
239 RENAL TRANSPLANT 11 0.0030
240 CYTOMEGALOVIRUS COLITIS 7 0.0030
241 ACUTE RESPIRATORY FAILURE 58 0.0030
242 PROTEIN TOTAL INCREASED 8 0.0030
243 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 77 0.0030
244 DRUG ERUPTION 52 0.0029
245 HERPES SIMPLEX 19 0.0029
246 HYPOGAMMAGLOBULINAEMIA 19 0.0029
247 RESPIRATORY FAILURE 209 0.0029
248 ODYNOPHAGIA 17 0.0028
249 HYPERVOLAEMIA 14 0.0028
250 LYMPHOPENIA 40 0.0028
251 SEPTIC SHOCK 123 0.0028
252 BLOOD IMMUNOGLOBULIN G DECREASED 7 0.0028
253 BLOOD BILIRUBIN INCREASED 75 0.0028
254 URINARY TRACT INFECTION BACTERIAL 7 0.0028
255 RALES 16 0.0028
256 LIVER TRANSPLANT 10 0.0027
257 THROMBOCYTOPENIA 306 0.0027
258 DRUG LEVEL INCREASED 45 0.0027
259 MULTIPLE ORGAN DYSFUNCTION SYNDROME 77 0.0027
260 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 7 0.0027
261 ANHEDONIA 71 0.0027
262 DUODENAL ULCER 19 0.0027
263 PULMONARY TOXICITY 19 0.0027
264 HIV INFECTION 8 0.0027
265 RENAL TUBULAR NECROSIS 26 0.0026
266 VASCULAR DEVICE INFECTION 12 0.0026
267 DISSEMINATED INTRAVASCULAR COAGULATION 37 0.0026
268 HEPATIC ENZYME ABNORMAL 13 0.0026
269 SHOCK HAEMORRHAGIC 21 0.0026
270 ECONOMIC PROBLEM 39 0.0026
271 DIARRHOEA HAEMORRHAGIC 24 0.0026
272 OESOPHAGITIS 28 0.0026
273 PNEUMONIA VIRAL 8 0.0025
274 PLASMA CELL MYELOMA RECURRENT 8 0.0025
275 RETINAL VEIN OCCLUSION 7 0.0024
276 STEVENS-JOHNSON SYNDROME 54 0.0024
277 CANDIDA INFECTION 41 0.0024
278 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 6 0.0024
279 IMMUNOSUPPRESSION 21 0.0024
280 ACUTE RESPIRATORY DISTRESS SYNDROME 42 0.0024
281 TONGUE ULCERATION 8 0.0024
282 HISTIOCYTOSIS HAEMATOPHAGIC 7 0.0024
283 ESCHERICHIA URINARY TRACT INFECTION 10 0.0024
284 ATYPICAL PNEUMONIA 7 0.0023
285 AUTOIMMUNE HAEMOLYTIC ANAEMIA 8 0.0023
286 COLITIS 88 0.0023
287 OSTEOPENIA 35 0.0023
288 JAUNDICE 62 0.0023
289 ERYTHEMA NODOSUM 8 0.0023
290 PORTAL HYPERTENSION 7 0.0023
291 ERYTHEMA MULTIFORME 21 0.0022
292 NEUTROPENIA 306 0.0022
293 TRANSAMINASES INCREASED 50 0.0022
294 CHOLELITHIASIS 73 0.0022
295 BONE MARROW FAILURE 45 0.0022
296 BLOOD PRESSURE DIASTOLIC INCREASED 10 0.0022
297 LUNG INFILTRATION 19 0.0021
298 END STAGE RENAL DISEASE 39 0.0021
299 STOMACH DISCOMFORT 11 0.0021
300 GAMMA-GLUTAMYLTRANSFERASE INCREASED 47 0.0021
301 CHRONIC LYMPHOCYTIC LEUKAEMIA 10 0.0021
302 MENINGITIS 14 0.0021
303 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 8 0.0021
304 APHTHOUS ULCER 16 0.0021
305 RASH PUSTULAR 15 0.0021
306 EOSINOPHILIA 36 0.0021
307 ANOREXIA 26 0.0020
308 NEUTROPHIL COUNT DECREASED 82 0.0020
309 HEPATITIS ACUTE 13 0.0020
310 PSYCHOTIC DISORDER 59 0.0020
311 THROMBOTIC THROMBOCYTOPENIC PURPURA 7 0.0020
312 BONE MARROW DISORDER 6 0.0020
313 ACUTE KIDNEY INJURY 303 0.0020
314 ELECTROLYTE IMBALANCE 23 0.0020
315 LIPASE INCREASED 15 0.0020
316 NEPHROGENIC ANAEMIA 9 0.0019
317 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 16 0.0019
318 RENAL FUNCTION TEST ABNORMAL 9 0.0019
319 DERMATITIS BULLOUS 14 0.0019
320 LEUKOCYTOSIS 35 0.0019
321 TUMOUR LYSIS SYNDROME 17 0.0019
322 AMYLASE INCREASED 7 0.0019
323 HYPOPHOSPHATAEMIA 14 0.0019
324 CARDIAC DYSFUNCTION 7 0.0019
325 STAPHYLOCOCCAL INFECTION 62 0.0019
326 LEUKOENCEPHALOPATHY 7 0.0019
327 HYPOXIA 66 0.0019
328 HEPATIC NECROSIS 7 0.0019
329 SEPSIS 207 0.0019
330 ABNORMAL DREAMS 51 0.0018
331 BACTERIAL SEPSIS 6 0.0018
332 HYPERKALAEMIA 64 0.0018
333 HEPATIC FUNCTION ABNORMAL 68 0.0018
334 OESOPHAGEAL ULCER 7 0.0018
335 PLASMA CELL MYELOMA 71 0.0018
336 NECROSIS 10 0.0018
337 TOXIC SKIN ERUPTION 18 0.0018
338 DRUG-INDUCED LIVER INJURY 56 0.0018
339 PLATELET COUNT DECREASED 190 0.0018
340 LEUKOPENIA 89 0.0018
341 IRON DEFICIENCY 8 0.0018
342 CHOLANGITIS 11 0.0018
343 BACTERIAL INFECTION 33 0.0018
344 PYREXIA 611 0.0018
345 HEPATIC FAILURE 53 0.0018
346 HYPERLIPIDAEMIA 21 0.0018
347 SKIN LESION 48 0.0017
348 IMMUNE THROMBOCYTOPENIA 8 0.0017
349 SKIN PAPILLOMA 7 0.0017
350 APLASIA PURE RED CELL 6 0.0017
351 ALANINE AMINOTRANSFERASE INCREASED 106 0.0017
352 AUTOIMMUNE HEPATITIS 12 0.0017
353 GASTRITIS EROSIVE 8 0.0017
354 BLOOD LACTATE DEHYDROGENASE INCREASED 27 0.0017
355 PAPULE 12 0.0017
356 HYPERTHERMIA 13 0.0017
357 PHARYNGOLARYNGEAL PAIN 9 0.0017
358 HYPOCALCAEMIA 32 0.0017
359 VIRAL UPPER RESPIRATORY TRACT INFECTION 8 0.0017
360 RECALLED PRODUCT ADMINISTERED 16 0.0017
361 ANAL ABSCESS 9 0.0017
362 GINGIVITIS 9 0.0017
363 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 91 0.0017
364 LYMPHOCYTE COUNT DECREASED 29 0.0016
365 HEPATOCELLULAR INJURY 23 0.0016
366 PROTEIN URINE PRESENT 8 0.0016
367 HYPOPHAGIA 41 0.0016
368 ABORTION INDUCED 15 0.0016
369 CHEMOTHERAPY 6 0.0016
370 ABDOMINAL ABSCESS 7 0.0016
371 DYSLIPIDAEMIA 8 0.0016
372 VENTRICULAR SEPTAL DEFECT 9 0.0016
373 ALTERED STATE OF CONSCIOUSNESS 34 0.0016
374 VISUAL DISTURBANCE 9 0.0016
375 BRAIN NEOPLASM MALIGNANT 7 0.0016
376 SHOCK 36 0.0016
377 ASPARTATE AMINOTRANSFERASE INCREASED 83 0.0016
378 ENTEROCOLITIS 9 0.0016
379 METABOLIC DISORDER 9 0.0015
380 SUSPECTED OFF LABEL USE 7 0.0015
381 HYPOALBUMINAEMIA 12 0.0015
382 SPLENOMEGALY 18 0.0015
383 DISEASE COMPLICATION 7 0.0015
384 PLEURAL EFFUSION 93 0.0015
385 BLOOD LACTIC ACID INCREASED 8 0.0015
386 NEPHROPATHY TOXIC 17 0.0015
387 PANCREATITIS ACUTE 34 0.0015
388 GASTROENTERITIS 22 0.0015
389 PNEUMONITIS 41 0.0015
390 AZOTAEMIA 6 0.0015
391 SKIN MASS 10 0.0015
392 BLOOD PRESSURE DIASTOLIC DECREASED 11 0.0015
393 BLOOD ALKALINE PHOSPHATASE INCREASED 37 0.0015
394 INTERSTITIAL LUNG DISEASE 72 0.0015
395 HEPATIC ENZYME INCREASED 100 0.0015
396 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 14 0.0015
397 FAECALOMA 8 0.0015
398 ISCHAEMIC STROKE 26 0.0015
399 MYELODYSPLASTIC SYNDROME 21 0.0015
400 LARGE INTESTINE PERFORATION 10 0.0014
401 PETECHIAE 15 0.0014
402 RED BLOOD CELL COUNT DECREASED 41 0.0014
403 DRUG INTERACTION 227 0.0014
404 HAEMOGLOBIN ABNORMAL 9 0.0014
405 FULL BLOOD COUNT DECREASED 28 0.0014
406 TREATMENT FAILURE 115 0.0014
407 BLOOD PRESSURE SYSTOLIC INCREASED 27 0.0014
408 PERICARDIAL EFFUSION 32 0.0014
409 CHAPPED LIPS 6 0.0014
410 HALLUCINATION 104 0.0014
411 LEUKAEMIA 13 0.0014
412 NEUTROPHIL COUNT INCREASED 14 0.0014
413 CEREBRAL DISORDER 10 0.0014
414 RASH GENERALISED 35 0.0014
415 SKIN NECROSIS 7 0.0013
416 IMMUNODEFICIENCY 20 0.0013
417 QUALITY OF LIFE DECREASED 18 0.0013
418 HYDRONEPHROSIS 10 0.0013
419 LIVER DISORDER 59 0.0013
420 CHROMATURIA 30 0.0013
421 HEPATITIS 34 0.0013
422 HEPATITIS CHOLESTATIC 8 0.0013
423 ASCITES 39 0.0013
424 DRUG EXPOSURE DURING PREGNANCY 45 0.0013
425 PNEUMONIA 425 0.0013
426 FACE OEDEMA 22 0.0013
427 RENAL FAILURE 173 0.0013
428 DECREASED ACTIVITY 14 0.0013
429 CLOSTRIDIUM DIFFICILE INFECTION 28 0.0013
430 CHILLS 150 0.0013
431 DRUG LEVEL DECREASED 13 0.0013
432 ANAEMIA 242 0.0013
433 LIVER INJURY 31 0.0013
434 NEUROTOXICITY 22 0.0013
435 WHITE BLOOD CELL COUNT ABNORMAL 8 0.0013
436 MALNUTRITION 14 0.0013
437 DISEASE PROGRESSION 148 0.0012
438 RENAL IMPAIRMENT 105 0.0012
439 PURPURA 11 0.0012
440 ATELECTASIS 12 0.0012
441 LYMPHOMA 19 0.0012
442 MYOSITIS 11 0.0012
443 HEPATOMEGALY 12 0.0012
444 ORAL CANDIDIASIS 16 0.0012
445 DYSGRAPHIA 8 0.0012
446 HYPOKALAEMIA 56 0.0012
447 SPINAL COMPRESSION FRACTURE 10 0.0012
448 LUNG DISORDER 59 0.0012
449 VASCULITIS 14 0.0012
450 HYPOVOLAEMIA 7 0.0012
451 HYPERTRIGLYCERIDAEMIA 7 0.0012
452 DYSPNOEA EXERTIONAL 45 0.0012
453 HAEMODIALYSIS 10 0.0012
454 CELLULITIS 60 0.0012
455 TACHYPNOEA 16 0.0012
456 ECCHYMOSIS 8 0.0012
457 BLOOD CREATININE INCREASED 76 0.0012
458 RESPIRATORY DISTRESS 32 0.0012
459 MYOPATHY 10 0.0012
460 MULTI-ORGAN FAILURE 20 0.0012
461 ENCEPHALITIS 8 0.0012
462 PYELONEPHRITIS 10 0.0012
463 ADRENAL INSUFFICIENCY 14 0.0012
464 MENTAL STATUS CHANGES 32 0.0012
465 HYPOMAGNESAEMIA 16 0.0011
466 SKIN REACTION 16 0.0011
467 BLOOD ALBUMIN DECREASED 9 0.0011
468 COVID-19 199 0.0011
469 SINUS TACHYCARDIA 16 0.0011
470 WHITE BLOOD CELL COUNT DECREASED 122 0.0011
471 HYPERGLYCAEMIA 41 0.0011
472 NIGHT SWEATS 36 0.0011
473 DISEASE RECURRENCE 53 0.0011
474 FUNGAL INFECTION 37 0.0011
475 CHEILITIS 6 0.0011
476 NIGHTMARE 38 0.0011
477 ACUTE HEPATIC FAILURE 15 0.0011
478 ENTERITIS 7 0.0011
479 UPPER-AIRWAY COUGH SYNDROME 9 0.0011
480 RED BLOOD CELL SEDIMENTATION RATE INCREASED 12 0.0011
481 GRAND MAL CONVULSION 10 0.0011
482 BLOOD UREA INCREASED 18 0.0011
483 C-REACTIVE PROTEIN INCREASED 39 0.0011
484 LIVER FUNCTION TEST INCREASED 23 0.0011
485 MUCOSAL INFLAMMATION 28 0.0011
486 CONDITION AGGRAVATED 325 0.0011
487 OXYGEN SATURATION DECREASED 60 0.0011
488 LIVER FUNCTION TEST ABNORMAL 31 0.0011
489 REBOUND EFFECT 12 0.0011
490 RENAL FAILURE ACUTE 45 0.0011
491 GOUT 19 0.0011
492 OFF LABEL USE 927 0.0011
493 GLOMERULAR FILTRATION RATE DECREASED 13 0.0011
494 STOMATITIS 64 0.0011
495 BONE DENSITY DECREASED 33 0.0011
496 INTERNATIONAL NORMALISED RATIO INCREASED 30 0.0011
497 PARANOIA 18 0.0010
498 MATERNAL DRUGS AFFECTING FOETUS 8 0.0010
499 BLOOD MAGNESIUM DECREASED 9 0.0010
500 OEDEMA PERIPHERAL 127 0.0010
501 PHARMACEUTICAL PRODUCT COMPLAINT 27 0.0010
502 DEVICE RELATED INFECTION 16 0.0010
503 BLOOD URIC ACID INCREASED 6 0.0010
504 DIARRHOEA 668 0.0010
505 MATERNAL EXPOSURE BEFORE PREGNANCY 7 0.0010
506 VIRAL INFECTION 34 0.0010
507 OSTEOPOROSIS 42 0.0010
508 DEEP VEIN THROMBOSIS 66 0.0010
509 PNEUMOTHORAX 16 0.0010
510 PULMONARY MASS 15 0.0010
511 HYPERTRANSAMINASAEMIA 7 0.0010
512 TACHYCARDIA 89 0.0010
513 CHRONIC KIDNEY DISEASE 76 0.0010
514 MELAENA 22 0.0010
515 VISUAL ACUITY REDUCED 33 0.0010
516 RHINITIS 8 0.0010
517 SEASONAL ALLERGY 14 0.0010
518 TREATMENT NONCOMPLIANCE 54 0.0010
519 BLOOD POTASSIUM INCREASED 16 0.0010
520 POLYURIA 8 0.0010
521 UROSEPSIS 9 0.0010
522 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
523 HYPERCALCAEMIA 12 0.0010
524 GENERALISED TONIC-CLONIC SEIZURE 16 0.0010
525 MENSTRUAL DISORDER 8 0.0010
526 NEPHROPATHY 9 0.0010
527 DIPLOPIA 25 0.0010
528 FAECES SOFT 7 0.0010
529 MYOCARDITIS 11 0.0010
530 INTENTIONAL UNDERDOSE 7 0.0010
531 FULL BLOOD COUNT ABNORMAL 10 0.0009
532 HAEMOGLOBIN DECREASED 97 0.0009
533 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
534 CIRCULATORY COLLAPSE 16 0.0009
535 VOMITING 441 0.0009
536 ORAL PAIN 21 0.0009
537 TASTE DISORDER 19 0.0009
538 BONE LOSS 14 0.0009
539 BODY TEMPERATURE INCREASED 19 0.0009
540 HAEMATOMA 24 0.0009
541 WOUND INFECTION 10 0.0009
542 MULTIPLE FRACTURES 15 0.0009
543 GASTROINTESTINAL PAIN 10 0.0009
544 PARALYSIS 13 0.0009
545 CORONAVIRUS INFECTION 6 0.0009
546 METABOLIC ACIDOSIS 29 0.0009
547 PANIC ATTACK 33 0.0009
548 ANAL INCONTINENCE 8 0.0009
549 HYPONATRAEMIA 50 0.0009
550 PRODUCT TASTE ABNORMAL 12 0.0009
551 DEPRESSED LEVEL OF CONSCIOUSNESS 35 0.0009
552 INFECTION 126 0.0009
553 VENTRICULAR EXTRASYSTOLES 9 0.0009
554 APHASIA 26 0.0009
555 HAEMOPTYSIS 24 0.0009
556 HEPATIC STEATOSIS 16 0.0009
557 TRANSFUSION 9 0.0009
558 RENAL DISORDER 40 0.0009
559 BLOOD COUNT ABNORMAL 13 0.0009
560 HEPATIC ENCEPHALOPATHY 8 0.0009
561 HAEMATOCRIT DECREASED 17 0.0009
562 FLANK PAIN 8 0.0009
563 HALLUCINATION, VISUAL 18 0.0009
564 SKIN ULCER 22 0.0009
565 SQUAMOUS CELL CARCINOMA 8 0.0008
566 BLOOD SODIUM DECREASED 16 0.0008
567 DIALYSIS 12 0.0008
568 DEAFNESS 22 0.0008
569 NEUROPATHY PERIPHERAL 80 0.0008
570 HERPES ZOSTER 48 0.0008
571 RASH 363 0.0008
572 PARAESTHESIA ORAL 12 0.0008
573 ATRIAL FIBRILLATION 81 0.0008
574 OSTEOMYELITIS 15 0.0008
575 PRODUCT USE IN UNAPPROVED INDICATION 204 0.0008
576 SENSORY DISTURBANCE 13 0.0008
577 HOSPICE CARE 8 0.0008
578 ARTHROPOD BITE 6 0.0008
579 GENERALISED OEDEMA 10 0.0008
580 THINKING ABNORMAL 15 0.0008
581 HAEMORRHAGE INTRACRANIAL 12 0.0008
582 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
583 WHEEZING 47 0.0008
584 DECREASED APPETITE 184 0.0008
585 BRAIN OEDEMA 10 0.0008
586 LYMPHADENOPATHY 28 0.0008
587 MANIA 13 0.0008
588 MUSCLE ATROPHY 10 0.0008
589 SCAB 9 0.0008
590 HAEMATURIA 27 0.0008
591 DRUG DISPENSING ERROR 12 0.0008
592 BLISTER 44 0.0008
593 PRESYNCOPE 19 0.0008
594 MYDRIASIS 10 0.0008
595 DELIRIUM 27 0.0008
596 COUGH 218 0.0008
597 PANCREATITIS 41 0.0008
598 EPISTAXIS 58 0.0008
599 DELUSION 12 0.0008
600 THERAPY PARTIAL RESPONDER 12 0.0008
601 SUBDURAL HAEMATOMA 11 0.0008
602 NAUSEA 608 0.0008
603 TENDERNESS 8 0.0008
604 GASTRITIS 20 0.0008
605 TOOTH INFECTION 10 0.0008
606 PULMONARY CONGESTION 10 0.0008
607 RASH PRURITIC 41 0.0008
608 WHITE BLOOD CELL COUNT INCREASED 29 0.0008
609 CHOLECYSTITIS 9 0.0008
610 RASH ERYTHEMATOUS 36 0.0008
611 ATRIAL FLUTTER 6 0.0008
612 PRESCRIBED UNDERDOSE 15 0.0008
613 DEHYDRATION 100 0.0007
614 ABDOMINAL PAIN 174 0.0007
615 LABORATORY TEST ABNORMAL 22 0.0007
616 LOCALISED INFECTION 18 0.0007
617 RASH MACULAR 26 0.0007
618 POOR QUALITY SLEEP 16 0.0007
619 CHEST PAIN 137 0.0007
620 FEEDING DISORDER 15 0.0007
621 ASPIRATION 8 0.0007
622 PHOTOSENSITIVITY REACTION 12 0.0007
623 PHARYNGITIS 9 0.0007
624 ACUTE CORONARY SYNDROME 6 0.0007
625 ELECTROCARDIOGRAM QT PROLONGED 26 0.0007
626 DIZZINESS POSTURAL 7 0.0007
627 PNEUMONIA ASPIRATION 18 0.0007
628 COAGULOPATHY 12 0.0007
629 INSURANCE ISSUE 11 0.0007
630 AUTOIMMUNE DISORDER 7 0.0007
631 DERMATITIS ALLERGIC 9 0.0007
632 PULMONARY OEDEMA 32 0.0007
633 INTESTINAL PERFORATION 8 0.0007
634 ACUTE MYOCARDIAL INFARCTION 21 0.0007
635 DYSPNOEA 403 0.0007
636 ABDOMINAL PAIN LOWER 18 0.0007
637 LACTIC ACIDOSIS 23 0.0007
638 STATUS EPILEPTICUS 8 0.0007
639 BLOOD PRESSURE FLUCTUATION 17 0.0007
640 AMNESIA 46 0.0007
641 OEDEMA 38 0.0007
642 ABORTION SPONTANEOUS 28 0.0007
643 BRAIN INJURY 7 0.0007
644 HYPOTENSION 139 0.0007
645 GENERAL PHYSICAL HEALTH DETERIORATION 80 0.0007
646 PLATELET COUNT INCREASED 9 0.0007
647 EPILEPSY 21 0.0007
648 CONTUSION 66 0.0007
649 IMMUNE SYSTEM DISORDER 9 0.0007
650 DISORIENTATION 27 0.0007
651 INTENTIONAL PRODUCT USE ISSUE 59 0.0007
652 PRESCRIBED OVERDOSE 13 0.0007
653 RHABDOMYOLYSIS 28 0.0007
654 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 35 0.0007
655 ANXIETY 190 0.0007
656 ASTHENIA 251 0.0007
657 UVEITIS 9 0.0007
658 BLOOD CREATINE PHOSPHOKINASE INCREASED 19 0.0007
659 RESTLESSNESS 24 0.0007
660 SPINAL FRACTURE 13 0.0006
661 FAECES DISCOLOURED 14 0.0006
662 EMOTIONAL DISTRESS 78 0.0006
663 DYSPHAGIA 61 0.0006
664 MIDDLE INSOMNIA 12 0.0006
665 PULMONARY THROMBOSIS 7 0.0006
666 ABDOMINAL PAIN UPPER 132 0.0006
667 INFLAMMATION 33 0.0006
668 URTICARIA 107 0.0006
669 GASTROINTESTINAL DISORDER 57 0.0006
670 INFUSION RELATED REACTION 42 0.0006
671 FOOT FRACTURE 12 0.0006
672 BLOOD URINE PRESENT 12 0.0006
673 FEAR 17 0.0006
674 CONFUSIONAL STATE 102 0.0006
675 PRODUCTIVE COUGH 30 0.0006
676 HOSPITALISATION 96 0.0006
677 SEROTONIN SYNDROME 12 0.0006
678 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 44 0.0006
679 MITRAL VALVE INCOMPETENCE 7 0.0006
680 FLUID OVERLOAD 9 0.0006
681 NEURALGIA 15 0.0006
682 DYSSTASIA 18 0.0006
683 GALLBLADDER DISORDER 11 0.0006
684 SWELLING FACE 40 0.0006
685 CEREBRAL INFARCTION 15 0.0006
686 MYELOSUPPRESSION 22 0.0006
687 OSTEONECROSIS 20 0.0006
688 LETHARGY 35 0.0006
689 PALPITATIONS 71 0.0006
690 DYSGEUSIA 45 0.0006
691 BLOOD PRESSURE ABNORMAL 12 0.0006
692 FOETAL EXPOSURE DURING PREGNANCY 49 0.0006
693 RESPIRATORY DISORDER 18 0.0006
694 INFLUENZA 67 0.0006
695 THERAPY NON-RESPONDER 27 0.0006
696 HEART RATE DECREASED 21 0.0006
697 WEIGHT DECREASED 166 0.0006
698 SINUS CONGESTION 8 0.0006
699 THROAT TIGHTNESS 16 0.0006
700 CONSTIPATION 129 0.0006
701 BLOOD IRON DECREASED 7 0.0006
702 PULMONARY EMBOLISM 56 0.0006
703 NEPHROLITHIASIS 27 0.0006
704 ANGIOEDEMA 26 0.0006
705 MYOCLONUS 7 0.0006
706 GASTROINTESTINAL HAEMORRHAGE 49 0.0006
707 LUNG NEOPLASM MALIGNANT 24 0.0006
708 GASTROOESOPHAGEAL REFLUX DISEASE 47 0.0006
709 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 28 0.0006
710 FRACTURE 11 0.0006
711 MUSCULAR WEAKNESS 66 0.0006
712 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 17 0.0006
713 RASH PAPULAR 13 0.0006
714 THERAPEUTIC RESPONSE UNEXPECTED 26 0.0006
715 EJECTION FRACTION DECREASED 9 0.0006
716 PULMONARY HYPERTENSION 12 0.0006
717 RESPIRATORY TRACT INFECTION 15 0.0006
718 LOCAL SWELLING 10 0.0006
719 MASS 8 0.0006
720 PRODUCT AVAILABILITY ISSUE 13 0.0006
721 SKIN DISORDER 19 0.0006
722 BLOOD TEST ABNORMAL 8 0.0006
723 ERUCTATION 11 0.0006
724 HALLUCINATION, AUDITORY 9 0.0006
725 BLOOD POTASSIUM DECREASED 17 0.0006
726 HEART RATE INCREASED 56 0.0006
727 EYE SWELLING 21 0.0006
728 EAR INFECTION 15 0.0006
729 ORAL HERPES 11 0.0006
730 ILEUS 7 0.0006
731 UPPER RESPIRATORY TRACT INFECTION 26 0.0006
732 IMPAIRED WORK ABILITY 12 0.0006
733 VISION BLURRED 77 0.0006
734 AGGRESSION 28 0.0006
735 DRUG INTOLERANCE 54 0.0006
736 HYPERSOMNIA 16 0.0006
737 CARDIOGENIC SHOCK 8 0.0006
738 RHINORRHOEA 36 0.0006
739 BLOOD PRESSURE INCREASED 85 0.0006
740 GASTROENTERITIS VIRAL 10 0.0006
741 OROPHARYNGEAL PAIN 51 0.0006
742 PRODUCT PRESCRIBING ISSUE 12 0.0006
743 FLUID RETENTION 28 0.0005
744 CRYING 20 0.0005
745 FATIGUE 427 0.0005
746 INSOMNIA 146 0.0005
747 EXPOSURE DURING PREGNANCY 34 0.0005
748 BONE PAIN 32 0.0005
749 SWOLLEN TONGUE 17 0.0005
750 CONVULSION 31 0.0005
751 VERTIGO 33 0.0005
752 HYPERTENSION 114 0.0005
753 MALAISE 235 0.0005
754 RIB FRACTURE 11 0.0005
755 DIZZINESS 265 0.0005
756 HYPOAESTHESIA ORAL 8 0.0005
757 ABDOMINAL DISCOMFORT 89 0.0005
758 ABDOMINAL DISTENSION 55 0.0005
759 GASTRIC DISORDER 18 0.0005
760 HEADACHE 328 0.0005
761 INFLUENZA LIKE ILLNESS 43 0.0005
762 SKIN DISCOLOURATION 24 0.0005
763 SYNCOPE 52 0.0005
764 DISTURBANCE IN ATTENTION 28 0.0005
765 EATING DISORDER 11 0.0005
766 IMPAIRED GASTRIC EMPTYING 7 0.0005
767 HAEMATEMESIS 13 0.0005
768 GINGIVAL BLEEDING 7 0.0005
769 HAEMORRHOIDS 10 0.0005
770 RECTAL HAEMORRHAGE 22 0.0005
771 HYPERSENSITIVITY 95 0.0005
772 COLD SWEAT 9 0.0005
773 PRURITUS GENERALISED 11 0.0005
774 INCORRECT PRODUCT ADMINISTRATION DURATION 11 0.0005
775 VAGINAL HAEMORRHAGE 22 0.0005
776 DIVERTICULITIS 14 0.0005
777 DYSARTHRIA 19 0.0005
778 URINARY TRACT INFECTION 86 0.0005
779 RESPIRATORY TRACT CONGESTION 8 0.0005
780 PREMATURE DELIVERY 8 0.0005
781 CARDIO-RESPIRATORY ARREST 21 0.0005
782 COORDINATION ABNORMAL 7 0.0005
783 APHONIA 7 0.0005
784 ABSCESS 8 0.0005
785 CHEST DISCOMFORT 51 0.0005
786 BONE DISORDER 9 0.0005
787 ILL-DEFINED DISORDER 30 0.0005
788 CARDIOMEGALY 6 0.0005
789 BLOOD GLUCOSE ABNORMAL 9 0.0005
790 BRONCHITIS 36 0.0005
791 CARDIAC FAILURE 39 0.0005
792 ABASIA 12 0.0005
793 HYPERTHYROIDISM 7 0.0005
794 DRY EYE 24 0.0005
795 APATHY 7 0.0005
796 TINNITUS 22 0.0005
797 DYSPHONIA 28 0.0005
798 PHOTOPHOBIA 9 0.0005
799 DERMATITIS 10 0.0005
800 MUSCLE TWITCHING 11 0.0005
801 CARDIOMYOPATHY 7 0.0005
802 CARDIAC ARREST 39 0.0005
803 MATERNAL EXPOSURE DURING PREGNANCY 42 0.0005
804 MYALGIA 80 0.0005
805 BACK PAIN 109 0.0005
806 LOWER LIMB FRACTURE 9 0.0005
807 FEELING COLD 13 0.0005
808 ANAPHYLACTIC SHOCK 12 0.0005
809 ARRHYTHMIA 22 0.0005
810 PRODUCT PRESCRIBING ERROR 11 0.0005
811 MENTAL DISORDER 20 0.0005
812 ORTHOSTATIC HYPOTENSION 8 0.0005
813 TREMOR 76 0.0005
814 DRY MOUTH 37 0.0005
815 DRUG INEFFECTIVE 601 0.0005
816 MENTAL IMPAIRMENT 11 0.0005
817 HYPOGLYCAEMIA 22 0.0005
818 HAEMATOCHEZIA 25 0.0005
819 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
820 TOXICITY TO VARIOUS AGENTS 76 0.0005
821 LUNG INFECTION 7 0.0005
822 LIP SWELLING 15 0.0004
823 TOOTH DISORDER 10 0.0004
824 SWELLING 42 0.0004
825 NERVOUS SYSTEM DISORDER 14 0.0004
826 GLOSSODYNIA 10 0.0004
827 BRAIN FOG 7 0.0004
828 BLINDNESS 18 0.0004
829 FEELING HOT 27 0.0004
830 ECZEMA 23 0.0004
831 URINARY INCONTINENCE 13 0.0004
832 PRURITUS 168 0.0004
833 DEPRESSION 99 0.0004
834 THERAPY CESSATION 22 0.0004
835 NASAL CONGESTION 25 0.0004
836 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
837 PERICARDITIS 7 0.0004
838 POST PROCEDURAL COMPLICATION 8 0.0004
839 MUSCLE SPASMS 76 0.0004
840 HYPERHIDROSIS 53 0.0004
841 SLEEP DISORDER 29 0.0004
842 ACCIDENTAL OVERDOSE 15 0.0004
843 ILLNESS 42 0.0004
844 KIDNEY INFECTION 8 0.0004
845 DIABETES MELLITUS 31 0.0004
846 LOSS OF CONSCIOUSNESS 52 0.0004
847 LIMB INJURY 11 0.0004
848 DISABILITY 8 0.0004
849 ABNORMAL BEHAVIOUR 16 0.0004
850 SKIN EXFOLIATION 34 0.0004
851 THROAT IRRITATION 18 0.0004
852 AGEUSIA 10 0.0004
853 PERIPHERAL SWELLING 61 0.0004
854 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
855 NECK PAIN 22 0.0004
856 BALANCE DISORDER 34 0.0004
857 BLOOD PRESSURE DECREASED 26 0.0004
858 SEIZURE 45 0.0004
859 PAIN IN JAW 11 0.0004
860 PARAESTHESIA 61 0.0004
861 PAIN 238 0.0004
862 CATARACT 23 0.0004
863 TYPE 2 DIABETES MELLITUS 13 0.0004
864 TOOTH LOSS 8 0.0004
865 DEATH 332 0.0004
866 SPEECH DISORDER 20 0.0004
867 CYANOSIS 6 0.0004
868 SINUSITIS 39 0.0004
869 DEPRESSED MOOD 20 0.0004
870 PRODUCT USE ISSUE 71 0.0004
871 CYSTITIS 12 0.0004
872 NEOPLASM MALIGNANT 25 0.0004
873 PRODUCT DOSE OMISSION ISSUE 110 0.0004
874 MOVEMENT DISORDER 12 0.0004
875 TUBULOINTERSTITIAL NEPHRITIS 7 0.0004
876 EYE PAIN 21 0.0004
877 SKIN CANCER 8 0.0004
878 RENAL INJURY 11 0.0004
879 UNEVALUABLE EVENT 28 0.0004
880 ADVERSE EVENT 34 0.0004
881 PROTEINURIA 7 0.0004
882 MUSCULOSKELETAL DISORDER 7 0.0004
883 AGITATION 27 0.0004
884 PALLOR 10 0.0004
885 FEELING JITTERY 7 0.0004
886 DYSPEPSIA 36 0.0004
887 CEREBRAL HAEMORRHAGE 13 0.0004
888 URINARY RETENTION 12 0.0004
889 BRADYCARDIA 19 0.0004
890 OCULAR HYPERAEMIA 17 0.0004
891 ADVERSE DRUG REACTION 32 0.0004
892 ERYTHEMA 73 0.0004
893 DYSURIA 13 0.0004
894 FLATULENCE 20 0.0004
895 UPPER LIMB FRACTURE 7 0.0004
896 GAIT DISTURBANCE 66 0.0003
897 HYPOTHYROIDISM 11 0.0003
898 ANAPHYLACTIC REACTION 19 0.0003
899 JOINT STIFFNESS 9 0.0003
900 BURNING SENSATION 24 0.0003
901 POLLAKIURIA 14 0.0003
902 COLITIS ULCERATIVE 15 0.0003
903 HYPOAESTHESIA 50 0.0003
904 EYE PRURITUS 11 0.0003
905 DRUG ADMINISTRATION ERROR 10 0.0003
906 OSTEONECROSIS OF JAW 8 0.0003
907 THROMBOSIS 26 0.0003
908 JOINT SWELLING 39 0.0003
909 NASOPHARYNGITIS 59 0.0003
910 CARDIAC FAILURE CONGESTIVE 25 0.0003
911 UNRESPONSIVE TO STIMULI 8 0.0003
912 SOMNOLENCE 62 0.0003
913 NERVOUSNESS 16 0.0003
914 ALOPECIA 59 0.0003
915 WEIGHT INCREASED 67 0.0003
916 VISUAL IMPAIRMENT 37 0.0003
917 ARTHRALGIA 124 0.0003
918 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
919 SUICIDAL IDEATION 27 0.0003
920 THERAPY INTERRUPTED 21 0.0003
921 DRY SKIN 39 0.0003
922 PAIN IN EXTREMITY 85 0.0003
923 PROCEDURAL PAIN 8 0.0003
924 MALIGNANT NEOPLASM PROGRESSION 29 0.0003
925 OSTEOARTHRITIS 12 0.0003
926 IRRITABILITY 17 0.0003
927 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
928 MOOD SWINGS 9 0.0003
929 THERAPEUTIC RESPONSE DECREASED 17 0.0003
930 FALL 93 0.0003
931 COGNITIVE DISORDER 13 0.0003
932 COMA 13 0.0003
933 INJURY 19 0.0003
934 ARTHROPATHY 15 0.0003
935 MEMORY IMPAIRMENT 37 0.0003
936 FEELING ABNORMAL 64 0.0003
937 ARTHRITIS 21 0.0003
938 ROAD TRAFFIC ACCIDENT 11 0.0003
939 DISCOMFORT 16 0.0003
940 LIMB DISCOMFORT 8 0.0003
941 HAEMORRHAGE 27 0.0003
942 BLOOD CHOLESTEROL INCREASED 12 0.0003
943 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
944 MEDICATION ERROR 14 0.0003
945 WOUND 7 0.0003
946 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 45 0.0002
947 HIP FRACTURE 8 0.0002
948 ANGINA PECTORIS 7 0.0002
949 HOT FLUSH 18 0.0002
950 INTESTINAL OBSTRUCTION 9 0.0002
951 PREMATURE BABY 7 0.0002
952 EMOTIONAL DISORDER 7 0.0002
953 FEMUR FRACTURE 7 0.0002
954 CEREBROVASCULAR ACCIDENT 38 0.0002
955 ACNE 17 0.0002
956 DYSKINESIA 9 0.0002
957 LOWER RESPIRATORY TRACT INFECTION 10 0.0002
958 PRODUCT DOSE OMISSION 14 0.0002
959 PRODUCT QUALITY ISSUE 29 0.0002
960 EYE DISORDER 7 0.0002
961 UNDERDOSE 15 0.0002
962 NEOPLASM PROGRESSION 7 0.0002
963 SUICIDE ATTEMPT 12 0.0002
964 MUSCULOSKELETAL PAIN 10 0.0002
965 MIGRAINE 18 0.0002
966 ASTHMA 21 0.0002
967 DRUG DOSE OMISSION 30 0.0002
968 ANGER 6 0.0002
969 OVERDOSE 37 0.0002
970 SURGERY 10 0.0002
971 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 12 0.0002
972 CARDIAC DISORDER 15 0.0002
973 EYE IRRITATION 9 0.0002
974 PRODUCT SUBSTITUTION ISSUE 9 0.0002
975 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
976 INTENTIONAL OVERDOSE 10 0.0002
977 MOBILITY DECREASED 11 0.0002
978 DERMATITIS ATOPIC 8 0.0002
979 MYOCARDIAL INFARCTION 26 0.0001
980 BLOOD GLUCOSE INCREASED 28 0.0001
981 INTENTIONAL PRODUCT MISUSE 13 0.0001
982 MUSCULOSKELETAL STIFFNESS 13 0.0001
983 FLUSHING 15 0.0001
984 INCORRECT DOSE ADMINISTERED 33 0.0001
985 PSORIASIS 18 0.0001
986 PRODUCT STORAGE ERROR 10 0.0001
987 NO ADVERSE EVENT 20 0.0001
988 COMPLETED SUICIDE 8 0.0001
989 INJECTION SITE HAEMORRHAGE 7 0.0001
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15 0.0001
991 INJECTION SITE ERYTHEMA 9 0.0001
992 RHEUMATOID ARTHRITIS 8 0.0001
993 INJECTION SITE PAIN 20 0.0001